Dr. Jagannath on Potential of Immunotherapy in Multiple Myeloma – OncLive
OncLiveDr. Jagannath on Potential of Immunotherapy in Multiple MyelomaOncLiveImmunotherapy approaches may overcome mutational burdens or drug resistance in the cancer cells of this disease, says Jagannath. Monoclonal antibodies such as daratumumab (Dar… Continue reading
